TY  - GEN
AU  - Passaro,A
AU  - Mancuso,P
AU  - Gandini,S
AU  - Spitaleri,G
AU  - Labanca,V
AU  - Guerini-Rocco,E
AU  - Barberis,M
AU  - Catania,C
AU  - Del Signore,E
AU  - de Marinis,F
AU  - Bertolini,F
TI  - Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
SN  - 1699-3055
PY  - 2021///0111
KW  - Aged
KW  - Biomarkers
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Female
KW  - Granulocytes
KW  - physiology
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - therapeutic use
KW  - Immunophenotyping
KW  - Immunotherapy
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Myeloid-Derived Suppressor Cells
KW  - Nivolumab
KW  - Prospective Studies
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s12094-019-02166-z
ER  -